{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:53:43Z","timestamp":1789149223681,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ethnopharmacology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.jep.2020.113462","type":"journal-article","created":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T12:07:27Z","timestamp":1602504447000},"page":"113462","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Tongmai Yangxin pill reduces myocardial No-reflow via endothelium-dependent NO-cGMP signaling by activation of the cAMP\/PKA pathway"],"prefix":"10.1016","volume":"267","author":[{"given":"Rui","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangdong","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinpeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 3","key":"10.1016\/j.jep.2020.113462_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/heartjnl-2015-307821","article-title":"British Cardiovascular Intervention society. Percutaneous coronary intervention in the UK: recommendations for good practice 2015","volume":"101","author":"Banning","year":"2015","journal-title":"Heart"},{"key":"10.1016\/j.jep.2020.113462_bib2","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.amjcard.2006.08.054","article-title":"Effect of no-reflow during primary percutaneous coronary intervention for acute myocardial infarction on six-month mortality","volume":"99","author":"Brosh","year":"2007","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.jep.2020.113462_bib3","doi-asserted-by":"crossref","first-page":"7786","DOI":"10.1073\/pnas.1608061113","article-title":"Gpr161 anchoring of PKA consolidates GPCR and cAMP signaling","volume":"113","author":"Bachmann","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jep.2020.113462_bib4","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.biopha.2018.09.095","article-title":"Tongmai Yangxin pills anti-oxidative stress alleviates cisplatin-induced cardiotoxicity: network pharmacology analysis and experimental evidence","volume":"108","author":"Cui","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jep.2020.113462_bib5","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jchromb.2018.09.038","article-title":"Clinical metabolomics analysis of therapeutic mechanism of Tongmai Yangxin Pill on stable angina","volume":"1100\u20131101","author":"Cai","year":"2018","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.jep.2020.113462_bib6","doi-asserted-by":"crossref","first-page":"113069","DOI":"10.1016\/j.jep.2020.113069","article-title":"Tongmai Yangxin pill reduces myocardial no-reflow by regulating apoptosis and activating PI3K\/Akt\/eNOS pathway","volume":"261","author":"Chen","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jep.2020.113462_bib7","first-page":"5553","article-title":"Molecular mechanism of Tongmai Yangxin Pills for angina and arrhythmia of the coronary heart disease based on integrative pharmacology","volume":"33","author":"Chen","year":"2018","journal-title":"Chin J Tradit Chin Med Pharm"},{"key":"10.1016\/j.jep.2020.113462_bib8","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ijcard.2015.03.359","article-title":"Novel insights into an \"old\" phenomenon: the no reflow","volume":"187","author":"Durante","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.jep.2020.113462_bib9","first-page":"856","article-title":"Tongmai Yangxin Wan for atrial arrhythmias of coronary heart disease: a clinical study","volume":"11","author":"Di","year":"2019","journal-title":"Chin J Evid Based Cardiovasc Med"},{"key":"10.1016\/j.jep.2020.113462_bib10","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.ahj.2010.02.019","article-title":"Endothelin-1 release in acute myocardial infarction as a predictor of long-term prognosis and no-reflow assessed by contrast-enhanced magnetic resonance imaging","volume":"159","author":"Eitel","year":"2010","journal-title":"Am. Heart J."},{"key":"10.1016\/j.jep.2020.113462_bib11","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1053\/euhj.2000.2172","article-title":"The coronary no-reflow phenomenon: a review of mechanisms and therapies","volume":"22","author":"Eeckhout","year":"2001","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jep.2020.113462_bib12","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.recesp.2010.07.001","article-title":"Usefulness of endothelin-1 assessment in acute myocardial infarction","volume":"64","author":"Freixa","year":"2011","journal-title":"Rev. Esp. Cardiol."},{"key":"10.1016\/j.jep.2020.113462_bib13","doi-asserted-by":"crossref","first-page":"153171","DOI":"10.1016\/j.phymed.2020.153171","article-title":"High content screening identifies licoisoflavone A as a bioactive compound of Tongmaiyangxin Pills to restrain cardiomyocyte hypertrophy via activating Sirt3","volume":"68","author":"Guo","year":"2020","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jep.2020.113462_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00395-015-0464-y","article-title":"Reduction of no-reflow and reperfusion injury with the synthetic 17beta-aminoestrogen compound Prolame is associated with PI3K\/Akt\/eNOS signaling cascade","volume":"110","author":"Hernandez-Resendiz","year":"2015","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.jep.2020.113462_bib15","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jcin.2014.06.005","article-title":"Appropriate use criteria: lessons from Japan","volume":"7","author":"Hung","year":"2014","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.jep.2020.113462_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182746","article-title":"REM sleep deprivation induces endothelial dysfunction and hypertension in middle-aged rats: roles of the eNOS\/NO\/cGMP pathway and supplementation with L-arginine","volume":"12","author":"Jiang","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.jep.2020.113462_bib17","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/j.2040-4603.2017.tb00741.x","article-title":"Ischemia\/reperfusion","volume":"7","author":"Kalogeris","year":"2016","journal-title":"Comp. Physiol."},{"key":"10.1016\/j.jep.2020.113462_bib18","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1080\/14779072.2019.1653187","article-title":"Coronary no-reflow in the modern era: a review of advances in diagnostic techniques and contemporary management","volume":"17","author":"Kumar","year":"2019","journal-title":"Expert Rev. Cardiovasc Ther."},{"key":"10.1016\/j.jep.2020.113462_bib19","first-page":"52","article-title":"Effects of tirofiban on the reperfusion-related no-reflow in rats with acute myocardial infarction","volume":"10","author":"Liu","year":"2013","journal-title":"J Geriatr Cardiol"},{"key":"10.1016\/j.jep.2020.113462_bib20","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/aps.2012.27","article-title":"Phosphorylation of endothelial NOS contributes to simvastatin protection against myocardial no-reflow and infarction in reperfused swine hearts: partially via the PKA signaling pathway","volume":"33","author":"Li","year":"2012","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.jep.2020.113462_bib21","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3892\/etm.2020.8688","article-title":"Lidocaine improves cerebral ischemia-reperfusion injury in rats through cAMP\/PKA signaling pathway","volume":"20","author":"Liu","year":"2020","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.jep.2020.113462_bib22","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.mvr.2012.04.002","article-title":"PKA-mediated eNOS phosphorylation in the protection of ischemic preconditioning against no-reflow","volume":"84","author":"Li","year":"2012","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.jep.2020.113462_bib23","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s11605-008-0728-z","article-title":"Nitroglycerin protects small intestine from ischemia-reperfusion injury via NO-cGMP pathway and upregulation of alpha-CGRP","volume":"13","author":"Li","year":"2009","journal-title":"J. Gastrointest. Surg."},{"key":"10.1016\/j.jep.2020.113462_bib24","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.yjmcc.2006.05.023","article-title":"Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation","volume":"42","author":"Mount","year":"2007","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.jep.2020.113462_bib25","first-page":"84","article-title":"Clinical effect of Tongmai Yangxin pill in treating coronary heart disease patients complicated with angina pectoris and the impact on vascular endothelial function","author":"Meng","year":"2016","journal-title":"Pract J Cardiac Cereb Pneum Vasc Dis"},{"key":"10.1016\/j.jep.2020.113462_bib26","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1074\/jbc.M209219200","article-title":"Protein kinase A-mediated phosphorylation of the Galpha13 switch I region alters the Galphabetagamma13-G protein-coupled receptor complex and inhibits Rho activation","volume":"278","author":"Manganello","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jep.2020.113462_bib27","doi-asserted-by":"crossref","first-page":"8467","DOI":"10.1128\/MCB.22.24.8467-8477.2002","article-title":"Rho GTPase\/Rho kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase B\/Akt in human endothelial cells","volume":"22","author":"Ming","year":"2002","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.jep.2020.113462_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.apha.2016.05.001","article-title":"The endothelium-dependent nitric oxide-cGMP pathway","volume":"77","author":"M\u00f3nica","year":"2016","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.jep.2020.113462_bib29","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.carrev.2007.08.005","article-title":"The pathogenesis and treatment of no-reflow occurring during percutaneous coronary intervention","volume":"9","author":"Movahed","year":"2008","journal-title":"Cardiovasc. Revascularization Med."},{"key":"10.1016\/j.jep.2020.113462_bib30","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.2174\/1381612824666180911122230","article-title":"Tsalamandris S, tousoulis D. Coronary microcirculation and the No-reflow phenomenon","volume":"24","author":"Oikonomou","year":"2018","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.jep.2020.113462_bib31","series-title":"Chinese Pharmacopoeia Commission","author":"Pharmacopoeia of the people\u2019s republic of china","year":"2015"},{"key":"10.1016\/j.jep.2020.113462_bib32","doi-asserted-by":"crossref","first-page":"6460393","DOI":"10.1155\/2018\/6460393","article-title":"Development of a HPLC-MS\/MS method to determine 11 bioactive compounds in Tongmai Yangxin pill and application to a pharmacokinetic study in rats","author":"Shen","year":"2018","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.jep.2020.113462_bib33","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.yjmcc.2011.06.009","article-title":"Coronary no reflow","volume":"52","author":"Schwartz","year":"2012","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.jep.2020.113462_bib34","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1002\/jssc.201401481","article-title":"Rapid identification of anti-inflammatory compounds from Tongmai Yangxin Pills by liquid chromatography with high-resolution mass spectrometry and chemometric analysis","volume":"38","author":"Tao","year":"2015","journal-title":"J. Separ. Sci."},{"key":"10.1016\/j.jep.2020.113462_bib35","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1167\/iovs.12-10115","article-title":"Dilation of porcine retinal arterioles to cilostazol: roles of eNOS phosphorylation via cAMP\/protein kinase A and AMP-activated protein kinase and potassium channels","volume":"54","author":"Tanano","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jep.2020.113462_bib36","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s13063-020-4208-4","article-title":"Tongmai Yangxin intervening in myocardial remodeling after PCI for coronary heart disease: study protocol for a double-blind, randomized controlled trial","volume":"21","author":"Wang","year":"2020","journal-title":"Trials"},{"key":"10.1016\/j.jep.2020.113462_bib37","first-page":"172","article-title":"Clinical observation of Tongmai Yangxin pills and compound danshen tablets in treating 54 cases with chronic stable Angina qi-deficency and blood-stasis syndromes","volume":"21","author":"Wu","year":"2015","journal-title":"Chin J Exp Tradit Med Formul"},{"key":"10.1016\/j.jep.2020.113462_bib38","first-page":"393","article-title":"Rapid qualitative analysis of chemical constituents in Tongmai Yangxin pill by UPLC-Q-TOF-MS\/MS","volume":"38","author":"Wei","year":"2019","journal-title":"J Tianjin Univ Tradit Chin Med"},{"key":"10.1016\/j.jep.2020.113462_bib39","doi-asserted-by":"crossref","first-page":"g3859","DOI":"10.1136\/bmj.g3859","article-title":"Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis","volume":"348","author":"Windecker","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.jep.2020.113462_bib40","first-page":"326","article-title":"The effect of Tongmai Yangxin Pill on the inflammatory factors and oxidative stress induced by hypoxia-induced myocardial cells","volume":"52","author":"Wang","year":"2011","journal-title":"Chinese Journal of Traditional Chinese Medicine"},{"key":"10.1016\/j.jep.2020.113462_bib41","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0008-6363(02)00261-4","article-title":"Endothelin in myocardial ischaemia and reperfusion","volume":"55","author":"Wang","year":"2002","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.jep.2020.113462_bib42","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/j.ijcard.2012.12.049","article-title":"Myocardial 'no-reflow'--diagnosis, pathophysiology and treatment","volume":"167","author":"Wong","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.jep.2020.113462_bib44","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.bbrc.2016.03.110","article-title":"Tirofiban induces vasorelaxation of the coronary artery via an endothelium-dependent NO-cGMP signaling by activating the PI3K\/Akt\/eNOS pathway","volume":"474","author":"Xia","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jep.2020.113462_bib45","doi-asserted-by":"crossref","first-page":"22635","DOI":"10.1074\/jbc.273.35.22635","article-title":"Inducible nitric-oxide synthase generates superoxide from the reductase domain","volume":"273","author":"Xia","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jep.2020.113462_bib46","first-page":"552","article-title":"Effects of Tongmai Yangxin pill on myocardial hypertrophy caused by isopropylarterenol","volume":"31","author":"Xu","year":"2014","journal-title":"Tianjin J Tradit Chin Med"},{"key":"10.1016\/j.jep.2020.113462_bib47","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.freeradbiomed.2019.02.031","article-title":"Reactive species-induced microvascular dysfunction in ischemia\/reperfusion","volume":"135","author":"Yu","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.jep.2020.113462_bib48","first-page":"1751","article-title":"Quality control of Tongmai Yangxin pills","volume":"42","author":"Yan","year":"2011","journal-title":"Chinese Herbal Medicines"},{"issue":"11","key":"10.1016\/j.jep.2020.113462_bib49","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3389\/fphar.2020.00121","article-title":"Shenfu injection promotes vasodilation by enhancing eNOS activity through the PI3K\/akt signaling pathway in vitro","volume":"26","author":"Zhu","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jep.2020.113462_bib50","first-page":"4672","article-title":"[Vasodilation effect and mechanism of extraction of Tongmai Yangxin Pills (TMYX) on isolated rat mesenteric artery]","volume":"43","author":"Zhou","year":"2018","journal-title":"Zhongguo Zhongyao Zazhi"},{"key":"10.1016\/j.jep.2020.113462_bib51","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.ejcb.2006.01.002","article-title":"Phosphodiesterases and compartmentalized cAMP signalling in the heart","volume":"85","author":"Zaccolo","year":"2006","journal-title":"Eur. J. Cell Biol."}],"container-title":["Journal of Ethnopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874120333481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874120333481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T16:42:39Z","timestamp":1759941759000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378874120333481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":50,"alternative-id":["S0378874120333481"],"URL":"https:\/\/doi.org\/10.1016\/j.jep.2020.113462","relation":{},"ISSN":["0378-8741"],"issn-type":[{"value":"0378-8741","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tongmai Yangxin pill reduces myocardial No-reflow via endothelium-dependent NO-cGMP signaling by activation of the cAMP\/PKA pathway","name":"articletitle","label":"Article Title"},{"value":"Journal of Ethnopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jep.2020.113462","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113462"}}